M. Arendrup, J. Bille, E. Dannaoui, M. Ruhnke, C. Heussel et al., ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia, Bone Marrow Transplantation, vol.106, issue.8, pp.1030-1075, 2012.
DOI : 10.1007/s00063-011-0045-2

J. Beardsley, M. Wolbers, F. Kibengo, A. Ggayi, A. Kamali et al., Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis, New England Journal of Medicine, vol.374, issue.6, pp.542-54, 2016.
DOI : 10.1056/NEJMoa1509024

J. Bennett, W. Dismukes, R. Duma, G. Medoff, M. Sande et al., A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis, N Engl J Med, vol.19301, issue.3, pp.126-157, 1979.

T. Beyene, A. Zewde, A. Balcha, B. Hirpo, T. Yitbarik et al., Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)???Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program, Clinical Infectious Diseases, vol.47, issue.12, pp.1-4, 2017.
DOI : 10.1086/593194

T. Bicanic, C. Bottomley, A. Loyse, A. Brouwer, C. Muzoora et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7224-7255, 2015.
DOI : 10.1128/AAC.01698-15

T. Bicanic, A. Brouwer, G. Meintjes, R. K. Limmathurotsakul, D. Chierakul et al., Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures, AIDS, issue.6, pp.2723-701, 2009.
DOI : 10.1097/QAD.0b013e32832605fe

T. Bicanic, G. Meintjes, R. Wood, M. Hayes, R. K. Bekker et al., Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole, Clinical Infectious Diseases, vol.20, issue.17, pp.76-80, 2007.
DOI : 10.1097/01.aids.0000252060.80704.68

T. Bicanic, C. Muzoora, A. Brouwer, G. Meintjes, N. Longley et al., Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV???Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients, Clinical Infectious Diseases, vol.49, issue.5, pp.702-711, 2009.
DOI : 10.1086/604716

D. Boulware, D. Meya, C. Muzoora, M. Rolfes, K. Hullsiek et al., Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis, New England Journal of Medicine, vol.370, issue.26, pp.2487-98, 2014.
DOI : 10.1056/NEJMoa1312884

D. Boulware, M. Rolfes, R. Rajasingham, M. Hohenberg-von, Z. Qin et al., Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast, Emerging Infectious Diseases, vol.20, issue.1, pp.45-53, 2014.
DOI : 10.3201/eid2001.130906

A. Brouwer, A. Rajanuwong, W. Chierakul, G. Griffin, R. Larsen et al., Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial, The Lancet, vol.363, issue.9423, pp.29363-1764, 2004.
DOI : 10.1016/S0140-6736(04)16301-0

A. Brouwer, P. Teparrukkul, S. Pinpraphaporn, R. Larsen, W. Chierakul et al., Baseline Correlation and Comparative Kinetics of Cerebrospinal Fluid Colony???Forming Unit Counts and Antigen Titers in Cryptococcal Meningitis, The Journal of Infectious Diseases, vol.192, issue.4, pp.681-685, 2005.
DOI : 10.1086/432073

A. Butts, K. Koselny, Y. Chabrier-roselló, C. Semighini, J. Brown et al., Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo, mBio, vol.5, issue.1, pp.765-778, 2014.
DOI : 10.1128/mBio.00765-13

J. Day, T. Chau, M. Wolbers, P. Mai, N. Dung et al., Combination Antifungal Therapy for Cryptococcal Meningitis, New England Journal of Medicine, vol.368, issue.14, pp.1291-302, 2013.
DOI : 10.1056/NEJMoa1110404

P. Desmet, K. Kayembe, and C. De-vroey, The value of cryptococcal serum antigen screening among HIV-positive, AIDS patients in Kinshasa Zaire. AIDS, vol.3, issue.2, pp.77-85, 1989.

F. Dromer, C. Bernede-bauduin, D. Guillemot, and O. Lortholary, Major Role for Amphotericin B???Flucytosine Combination in Severe Cryptococcosis, PLoS ONE, vol.51, issue.8, p.2870, 2008.
DOI : 10.1371/journal.pone.0002870.s003

F. Dromer, S. Mathoulin-pélissier, O. Launay, and O. Lortholary, Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study, PLoS Medicine, vol.21, issue.2, p.21, 2007.
DOI : 10.1371/journal.pmed.0040021.sd002

N. French, K. Gray, C. Watera, J. Nakiyingi, E. Lugada et al., Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults, AIDS, vol.16, issue.7, pp.1031-1039, 2002.
DOI : 10.1097/00002030-200205030-00009

K. Gaskell, C. Rothe, R. Gnanadurai, P. Goodson, C. Jassi et al., A Prospective Study of Mortality from Cryptococcal Meningitis following Treatment Induction with 1200mg Oral Fluconazole in Blantyre, Malawi, PLoS ONE, vol.63, issue.11, p.110285, 2014.
DOI : 10.1371/journal.pone.0110285.t001

J. Graybill, J. Sobel, M. Saag, C. Van-der-horst, W. Powderly et al., Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis, Clinical Infectious Diseases, vol.23, issue.1, pp.47-54, 2000.
DOI : 10.1093/clinids/23.1.194

R. Hamill, J. Sobel, W. El-sadr, P. Johnson, J. Graybill et al., Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS???Associated Acute Cryptococcal Meningitis: A Randomized, Double???Blind Clinical Trial of Efficacy and Safety, Clinical Infectious Diseases, vol.51, issue.2, pp.225-257, 2010.
DOI : 10.1086/653606

J. Jarvis, S. Lawn, M. Vogt, N. Bangani, R. Wood et al., Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa, Clinical Infectious Diseases, vol.48, issue.7, pp.856-62, 2009.
DOI : 10.1086/597262

J. Jarvis, T. Leeme, A. Chofle, G. Bidwell, M. Molefi et al., Ambition-cm: high-dose liposomal amphotericin for HIVrelated cryptococcal meningitis, Conference on retroviruses and opportunistic infections, 2017.

J. Jarvis, G. Meintjes, R. K. Williams, G. Bicanic, T. Williams et al., Adjunctive interferon-?? immunotherapy for the treatment of HIV-associated cryptococcal meningitis, AIDS, vol.26, issue.9, pp.1105-1118, 2012.
DOI : 10.1097/QAD.0b013e3283536a93

A. Kambugu, D. Meya, J. Rhein, O. Brien, M. Janoff et al., Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.12, issue.11, pp.1694-701, 2008.
DOI : 10.1111/j.1468-1293.2004.00201.x

D. Kontoyiannis, R. Lewis, B. Alexander, O. Lortholary, F. Dromer et al., Calcineurin Inhibitor Agents Interact Synergistically with Antifungal Agents In Vitro against Cryptococcus neoformans Isolates: Correlation with Outcome in Solid Organ Transplant Recipients with Cryptococcosis, Antimicrobial Agents and Chemotherapy, vol.52, issue.2, pp.735-743, 2008.
DOI : 10.1128/AAC.00990-07

R. Larsen, S. Bozzette, B. Jones, D. Haghighat, M. Leal et al., Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS, Clinical Infectious Diseases, vol.19, issue.4, pp.741-746, 1994.
DOI : 10.1093/clinids/19.4.741

A. Leenders, P. Reiss, P. Portegies, K. Clezy, W. Hop et al., Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis, AIDS, vol.11, issue.12, pp.1463-71, 1997.
DOI : 10.1097/00002030-199712000-00010

E. Letang, M. Müller, A. Ntamatungiro, N. Kimera, D. Faini et al., Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality, Open Forum Infectious Diseases, vol.4, issue.2, p.46, 2015.
DOI : 10.1371/journal.pone.0005790

N. Longley, J. Jarvis, G. Meintjes, A. Boulle, A. Cross et al., Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study, Clinical Infectious Diseases, vol.17, issue.5, pp.581-588, 2016.
DOI : 10.1111/hiv.12245

A. Loyse, D. Wilson, G. Meintjes, J. Jarvis, T. Bicanic et al., Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis, Clinical Infectious Diseases, vol.46, issue.11, pp.121-129, 2012.
DOI : 10.1086/587667

D. Meya, R. Rajasingham, E. Nalintya, M. Tenforde, and J. Jarvis, Preventing Cryptococcosis???Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy, Current Tropical Medicine Reports, vol.55, issue.12, pp.81-90, 2015.
DOI : 10.1093/cid/cis725

S. Mfinanga, C. D. Kivuyo, S. Guinness, L. Bottomley, C. Simms et al., Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial, The Lancet, vol.385, issue.9983, pp.2173-82, 2015.
DOI : 10.1016/S0140-6736(15)60164-7

M. Molefi, A. Chofle, S. Molloy, S. Kalluvya, J. Changalucha et al., AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial, Trials, vol.359, issue.9306, p.276, 2015.
DOI : 10.1016/S0140-6736(02)07750-4

S. Molloy, C. Kanyama, R. Heyderman, A. Loyse, C. Kouanfack et al., Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa, New England Journal of Medicine, vol.378, issue.11, pp.1004-1021, 2018.
DOI : 10.1056/NEJMoa1710922

J. Montezuma-rusca, J. Powers, D. Follmann, J. Wang, B. Sullivan et al., Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence, PLOS ONE, vol.317, issue.8, pp.159727-159742, 2016.
DOI : 10.1371/journal.pone.0159727.s006

C. Muzoora, T. Kabanda, G. Ortu, J. Ssentamu, P. Hearn et al., Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis, Journal of Infection, vol.64, issue.1, pp.76-81, 2012.
DOI : 10.1016/j.jinf.2011.10.014

P. Newton, L. Thai, N. Tip, J. Short, W. Chierakul et al., A Randomized, Double???Blind, Placebo???Controlled Trial of Acetazolamide for the Treatment of Elevated Intracranial Pressure in Cryptococcal Meningitis, Clinical Infectious Diseases, vol.26, issue.6, pp.769-72, 2002.
DOI : 10.1086/516298

J. Nussbaum, A. Jackson, D. Namarika, J. Phulusa, J. Kenala et al., Combination Flucytosine and High???Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi, Clinical Infectious Diseases, vol.50, issue.3, pp.338-382, 2010.
DOI : 10.1086/649861

P. Pappas, P. Chetchotisakd, R. Larsen, W. Manosuthi, M. Morris et al., A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV???Associated Cryptococcal Meningitis, Clinical Infectious Diseases, vol.48, issue.12, pp.1775-83, 2009.
DOI : 10.1086/599112

J. Perfect, W. Dismukes, F. Dromer, D. Goldman, J. Graybill et al., Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.50, issue.3, pp.291-322, 2010.
DOI : 10.1086/649858

J. Rhein, K. Hullsiek, L. Tugume, E. Nuwagira, E. Mpoza et al., Adjunctive sertraline in HIV-associated cryptococcal meningitis, Conference on retroviruses and opportunistic infections, 2018.

J. Rhein, B. Morawski, K. Hullsiek, H. Nabeta, R. Kiggundu et al., Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study, The Lancet Infectious Diseases, vol.16, issue.7, pp.809-827, 2016.
DOI : 10.1016/S1473-3099(16)00074-8

M. Rolfes, K. Hullsiek, J. Rhein, H. Nabeta, K. Taseera et al., The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis, Clinical Infectious Diseases, vol.14, issue.11, pp.1607-1621, 2014.
DOI : 10.1097/QAD.0b013e328322ffc3

C. Rothe, D. Sloan, P. Goodson, J. Chikafa, M. Mukaka et al., A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi, PLoS ONE, vol.53, issue.(1), p.67311, 2013.
DOI : 10.1371/journal.pone.0067311.t002

N. Singh, F. Dromer, J. Perfect, and O. Lortholary, Cryptococcosis in Solid Organ Transplant Recipients, American Journal of Transplantation, vol.7, issue.10, pp.1321-1328, 2008.
DOI : 10.1111/j.1600-6143.2007.02089.x

E. Temfack, C. Kouanfack, L. Mossiang, A. Loyse, M. Fonkoua et al., Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Na??ve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test, Frontiers in Microbiology, vol.8, p.9, 2018.
DOI : 10.1371/journal.pone.0062213

A. Temstet, P. Roux, J. Poirot, O. Ronin, and F. Dromer, Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies, J Clin Microbiol, vol.30, issue.10, pp.2544-50, 1992.

C. Van-der-horst, M. Saag, G. Cloud, R. Hamill, J. Graybill et al., Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome, New England Journal of Medicine, vol.337, issue.1, pp.15-21, 1997.
DOI : 10.1056/NEJM199707033370103

R. Wake, E. Britz, C. Sriruttan, I. Rukasha, T. Omar et al., High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients, Clinical Infectious Diseases, vol.95, issue.5, pp.686-92, 2018.
DOI : 10.4269/ajtmh.15-0857

W. Organization, Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy Available from: http://www.who.int/hiv, 2017.

W. Organization, Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children Available from: http:// www.who.int/hiv, 2018.

, WHO -World Health Organization Rapid Advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children, Geneva: World Health, 2011.

B. Zhai, C. Wu, L. Wang, M. Sachs, and X. Lin, ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3758-66, 2012.
DOI : 10.1128/AAC.00212-12